What are the off-label uses of Versed (midazolam)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Off-Label Uses of Midazolam (Versed)

Midazolam has numerous off-label applications beyond its FDA-approved indications, including treatment of seizures, delirium management in cancer patients, and as part of targeted temperature management protocols after cardiac arrest. 1

Seizure Management

  • Effective for acute seizure control and refractory status epilepticus when administered via multiple routes 1
  • Intramuscular dosing (0.2 mg/kg, maximum 6 mg per dose) can be repeated every 10-15 minutes for seizure control when IV access is unavailable 1
  • For refractory status epilepticus not controlled by standard therapies, can be administered as IV loading dose (0.15-0.20 mg/kg) followed by continuous infusion (1-5 mg/kg per minute) 1
  • Nasal administration is effective for acute seizure management, particularly in outpatient settings 2, 3

Procedural Applications

  • Sedation/anxiolysis for emergency department procedures at 0.05-0.10 mg/kg IV (maximum single dose: 5 mg) 1, 4
  • Oral administration at 0.25-0.50 mg/kg (maximum 20 mg) for pre-procedure sedation, with children under 6 potentially requiring up to 1 mg/kg 1
  • Adjunct for endotracheal intubation at 0.2 mg/kg IV, allowing 2-3 minutes for effect before administering muscle relaxant 1

Critical Care Applications

  • Management of delirium in cancer patients at 2.5 mg subcutaneous or IV every hour as needed (up to 5 mg maximum) 1
  • Lower doses (0.5-1 mg) recommended for older or frail patients, those with COPD, or when co-administered with antipsychotics 1
  • Used in targeted temperature management protocols after cardiac arrest, though propofol is often preferred for initial sedation due to midazolam's association with longer delirium 1

Pediatric Applications

  • Treatment of laryngotracheobronchitis (croup) at 1-2 mg/kg IV/IM (must use acetate salt for IM route) 1
  • Management of increased intracranial pressure in conjunction with other measures such as hyperventilation, head elevation, and cerebrospinal fluid drainage 1

Cardiovascular Applications

  • Treatment of infundibular spasm (hypercyanotic spell with tetralogy of Fallot) at 0.1 mg/kg IV or IM, repeating as necessary 1
  • Management of myocardial dysfunction and increased systemic/pulmonary vascular resistance (e.g., after cardiac surgery, normotensive septic shock) with loading dose of 50-75 mg/kg over 10-60 minutes, followed by infusion of 0.50-0.75 mg/kg per minute 1

Important Considerations and Precautions

  • Respiratory depression is a significant risk, particularly when combined with opioids or in elderly patients 5, 6
  • Reduced clearance in elderly, obese patients, and those with hepatic or renal impairment necessitates dose adjustments 5, 7
  • Paradoxical agitation may occur, especially in younger children 1
  • When used for delirium management, should be started on an as-needed basis before considering scheduled dosing 1
  • Flumazenil may be administered to reverse life-threatening respiratory depression, though this will also reverse anticonvulsant effects and may precipitate seizures 1, 6

Dosing Considerations

  • Careful titration to desired effect is essential to maximize safety 8, 4
  • Lower doses recommended for elderly patients and those with respiratory compromise 1, 7
  • Continuous monitoring of vital signs and oxygen saturation is necessary, especially when used in combination with other sedatives 1, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Midazolam Nasal Spray for Acute Seizure Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Midazolam: an effective intravenous agent for seizure control.

Archives of emergency medicine, 1987

Research

Midazolam use in the emergency department.

The American journal of emergency medicine, 1990

Guideline

Midazolam Pharmacokinetics and Stability

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Midazolam: a review of therapeutic uses and toxicity.

The Journal of emergency medicine, 1997

Research

Is midazolam a dangerous drug?

Journal of post anesthesia nursing, 1989

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.